• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者的对氧磷酶活性及表型分布

Paraoxonase Activity and Phenotype Distribution in Patients with Chronic Obstructive Pulmonary Disease.

作者信息

Sarioglu Nurhan, Bilen Cigdem, Cevik Celalettin, Gencer Nahit

机构信息

Department of Pulmonary Diseases, Balikesir University School of Medicine, Balikesir, Turkey.

Department of Chemistry, Yildiz Technical University, Faculty of Arts and Science, Istanbul, Turkey.

出版信息

Eurasian J Med. 2020 Jun;52(2):161-165. doi: 10.5152/eurasianjmed.2019.19122. Epub 2020 Jun 9.

DOI:10.5152/eurasianjmed.2019.19122
PMID:32612424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7311125/
Abstract

OBJECTIVE

Paraoxonase 1 (PON1) and arylesterase (ARE) enzymes have an important role in the prevention of oxidative stress which is related to the pathogenesis of chronic obstructive pulmonary disease (COPD). PON1 levels vary widely among individuals and ethnic groups, which is in part associated with polymorphisms.

MATERIALS AND METHODS

We investigated PON1 and ARE activity and phenotype distribution in COPD patients and healthy individuals. Sixty six COPD patients and 59 control subjects were involved in the study. Serum PON1 and ARE activities were detected by spectrophotometric method. The ratio of salt-induced PON1 to ARE activity was used to determine phenotypes as QQ, QR, and RR.

RESULTS

COPD patients exhibited higher PON1 activity (199.1 vs 129.2, p=0.002) but lower ARE activity compared to control (21.3 vs 33.5, p=0.021). There was a significant difference between COPD and control group with respect to PON1 phenotype characteristics. RR phenotypic distribution was more common in the COPD group than in control (60.6% [95% CI: 48.8 - 72.3] versus 22.0 % [95% CI: 12.0 - 31.9], p=0.001). We also found that smoking (95.0% CI: 0.001-0.036, p<0.001) and RR phenotype (95.0% CI: 0.006 - 0.59, p=0.016) are independent determinants in COPD.

CONCLUSION

We found that RR phenotype was more common in COPD patients compared to control. Smoking and RR phenotype may be defined as independent factors associated with COPD.

摘要

目的

对氧磷酶1(PON1)和芳基酯酶(ARE)在预防与慢性阻塞性肺疾病(COPD)发病机制相关的氧化应激中起重要作用。PON1水平在个体和种族群体中差异很大,这部分与基因多态性有关。

材料与方法

我们调查了COPD患者和健康个体的PON1和ARE活性及表型分布。66例COPD患者和59例对照受试者参与了本研究。采用分光光度法检测血清PON1和ARE活性。盐诱导的PON1与ARE活性之比用于确定QQ、QR和RR表型。

结果

与对照组相比,COPD患者的PON1活性较高(199.1对129.2,p = 0.002),但ARE活性较低(21.3对33.5,p = 0.021)。COPD组和对照组在PON1表型特征方面存在显著差异。RR表型分布在COPD组比对照组更常见(60.6% [95% CI:48.8 - 72.3] 对22.0% [95% CI:12.0 - 31.9],p = 0.001)。我们还发现吸烟(95.0% CI:0.001 - 0.036,p < 0.001)和RR表型(95.0% CI:0.006 - 0.59,p = 0.016)是COPD的独立决定因素。

结论

我们发现与对照组相比,RR表型在COPD患者中更常见。吸烟和RR表型可能被定义为与COPD相关的独立因素。

相似文献

1
Paraoxonase Activity and Phenotype Distribution in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者的对氧磷酶活性及表型分布
Eurasian J Med. 2020 Jun;52(2):161-165. doi: 10.5152/eurasianjmed.2019.19122. Epub 2020 Jun 9.
2
Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients.哮喘患者的对氧磷酶1表型和对氧磷酶活性
Iran J Allergy Asthma Immunol. 2015 Feb;14(1):60-6.
3
Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的对氧磷酶1活性
COPD. 2014 Sep;11(5):539-45. doi: 10.3109/15412555.2014.898028. Epub 2014 May 15.
4
Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction.探讨对氧磷酶-1基因变异与早发性心肌梗死发病率之间的联系。
Arch Med Sci. 2015 Jun 19;11(3):513-20. doi: 10.5114/aoms.2015.52353.
5
Paraoxonase 1 Activity and Phenotype Distribution in Lumbar Disc Herniation Patients.血清对氧磷酶 1 活性和表型分布在腰椎间盘突出症患者中的研究。
Turk Neurosurg. 2024;34(4):655-659. doi: 10.5137/1019-5149.JTN.44307-23.2.
6
The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypes.血清对氧磷酶(PON1)的盐刺激特性可能是评估缺血性中风时该酶状态的一个重要因素:基于活性测定的PON1 192Q/R表型的作用。
J Neurol Sci. 2014 Mar 15;338(1-2):197-202. doi: 10.1016/j.jns.2014.01.006. Epub 2014 Jan 9.
7
Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis.对氧磷酶1与慢性阻塞性肺疾病:一项荟萃分析
Antioxidants (Basel). 2021 Nov 26;10(12):1891. doi: 10.3390/antiox10121891.
8
gene polymorphisms in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的基因多态性。
J Clin Pathol. 2018 Nov;71(11):963-970. doi: 10.1136/jclinpath-2018-205194. Epub 2018 Jun 1.
9
Paraoxonase activity in healthy, diabetic, and hemodialysis patients.健康人群、糖尿病患者和血液透析患者的对氧磷酶活性。
Clin Biochem. 2012 Apr;45(6):470-4. doi: 10.1016/j.clinbiochem.2012.01.005. Epub 2012 Jan 18.
10
Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans.对硫磷酶 1 活性和基因多态性对芥子气暴露退伍军人长期肺部并发症的影响。
Int Immunopharmacol. 2013 Nov;17(3):974-9. doi: 10.1016/j.intimp.2012.12.026. Epub 2013 Jan 29.

引用本文的文献

1
Impact of smoking on redox homeostasis and 8-OHdG levels in COPD patients: a cross-sectional comparative study.吸烟对慢性阻塞性肺疾病患者氧化还原稳态和8-羟基脱氧鸟苷水平的影响:一项横断面比较研究。
BMC Pulm Med. 2025 Sep 2;25(1):423. doi: 10.1186/s12890-025-03907-3.
2
Bioinformatic Insights and XGBoost Identify Shared Genetics in Chronic Obstructive Pulmonary Disease and Type 2 Diabetes.生物信息学见解与XGBoost算法识别慢性阻塞性肺疾病和2型糖尿病的共同遗传学特征。
Clin Respir J. 2025 Mar;19(3):e70057. doi: 10.1111/crj.70057.
3
Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge.呼吸系统疾病中铜稳态失调:当前知识综述
Front Physiol. 2024 May 31;15:1243629. doi: 10.3389/fphys.2024.1243629. eCollection 2024.
4
Contribution of cuproptosis and Cu metabolism-associated genes to chronic obstructive pulmonary disease.铜死亡和铜代谢相关基因对慢性阻塞性肺疾病的贡献。
J Cell Mol Med. 2023 Dec;27(24):4034-4044. doi: 10.1111/jcmm.17985. Epub 2023 Oct 6.
5
Oxidative Stress and Air Pollution: Its Impact on Chronic Respiratory Diseases.氧化应激与空气污染:对慢性呼吸道疾病的影响。
Int J Mol Sci. 2023 Jan 3;24(1):853. doi: 10.3390/ijms24010853.
6
Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis.抑制性对氧磷酶 1 活性与类风湿关节炎患者氧化应激产物升高和小气道疾病存在相关。
Clin Rheumatol. 2023 Jan;42(1):75-82. doi: 10.1007/s10067-022-06375-w. Epub 2022 Sep 22.
7
Paraoxonase-1 Concentrations in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis.阻塞性睡眠呼吸暂停患者的对氧磷酶-1浓度:系统评价与荟萃分析
Antioxidants (Basel). 2022 Apr 12;11(4):766. doi: 10.3390/antiox11040766.
8
Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis.对氧磷酶1与慢性阻塞性肺疾病:一项荟萃分析
Antioxidants (Basel). 2021 Nov 26;10(12):1891. doi: 10.3390/antiox10121891.
9
The Role of Oxidative Stress in Sarcoidosis.氧化应激在结节病中的作用。
Int J Mol Sci. 2021 Oct 28;22(21):11712. doi: 10.3390/ijms222111712.

本文引用的文献

1
Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.在 2 型糖尿病中,对氧磷酶 1 与高密度脂蛋白和载脂蛋白 A1 的关系异常及其与高密度脂蛋白功能障碍的可能联系。
Diabetes Res Clin Pract. 2018 Jun;140:174-182. doi: 10.1016/j.diabres.2018.03.055. Epub 2018 Apr 5.
2
Relation of Paraoxonase 1 Activity with Biochemical Variables, Brachial Artery Intima-Media Thickness in Patients with Diabetes with or without Obesity.对伴有或不伴有肥胖的糖尿病患者,对氧磷酶 1 活性与生化变量、肱动脉内中膜厚度的关系研究。
Obes Facts. 2018;11(1):56-66. doi: 10.1159/000486513. Epub 2018 Feb 14.
3
The role of cholesterol-enriched diet and paraoxonase 1 inhibition in atherosclerosis progression.富含胆固醇的饮食和对氧磷酶1抑制在动脉粥样硬化进展中的作用。
J Cardiovasc Thorac Res. 2017;9(3):133-139. doi: 10.15171/jcvtr.2017.23. Epub 2017 Aug 31.
4
Metals and Paraoxonases.金属与对氧磷酶
Adv Neurobiol. 2017;18:85-111. doi: 10.1007/978-3-319-60189-2_5.
5
The inverse association of HDL-cholesterol with future risk of hypertension is not modified by its antioxidant constituent, paraoxonase-1: The PREVEND prospective cohort study.高密度脂蛋白胆固醇与未来高血压风险的负相关关系不受其抗氧化成分对氧磷酶-1的影响:PREVEND 前瞻性队列研究。
Atherosclerosis. 2017 Aug;263:219-226. doi: 10.1016/j.atherosclerosis.2017.06.353. Epub 2017 Jun 21.
6
Phenotyping Before Starting Treatment in COPD?慢性阻塞性肺疾病(COPD)开始治疗前进行表型分析?
COPD. 2017 Jun;14(3):367-374. doi: 10.1080/15412555.2017.1303041. Epub 2017 Apr 7.
7
Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery.冠状动脉手术期间对氧磷酶1对氧磷和苯乙酸酯活性的动态变化。
BMC Cardiovasc Disord. 2017 Apr 4;17(1):92. doi: 10.1186/s12872-017-0528-z.
8
Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms.慢性阻塞性肺疾病中的氧化应激:来源、标志物及潜在机制
J Clin Med. 2017 Feb 15;6(2):21. doi: 10.3390/jcm6020021.
9
[Interpretation of Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease (GOLD) 2016].《慢性阻塞性肺疾病全球诊断、管理和预防策略(GOLD)2016解读》
Zhonghua Yi Xue Za Zhi. 2016 Sep 13;96(34):2689-2691. doi: 10.3760/cma.j.issn.0376-2491.2016.34.001.
10
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的炎症机制。
J Allergy Clin Immunol. 2016 Jul;138(1):16-27. doi: 10.1016/j.jaci.2016.05.011. Epub 2016 May 27.